Dr. Brenda Iliana Magaña Trejo | Nanobiomedicine | Young Scientist Award

Posted on by ScienceFather

Dr. Brenda Iliana Magaña Trejo | Nanobiomedicine | Young Scientist Award

Doctorate at Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico

Profiles

Orcid

Academic Background

Dr. Brenda Iliana Magaña Trejo is a dedicated researcher at CINVESTAV Mexico, specializing in genetics, molecular biology, and nanomaterials. Her work focuses on the innovative application of trimethyl chitosan nanoparticles in immune cell studies, advancing the field of molecular biology through cutting-edge research.

Education

Dr. Brenda holds a Biotechnology Engineering degree from Quintana Roo’s Polytechnic University. She earned her Master’s and PhD in Genetics and Molecular Biology from CINVESTAV, completing her PhD in July 2024.

💼 Professional Experience

During her academic career, Dr. Brenda successfully synthesized trimethyl chitosan nanoparticles and explored their impact on lysosomal activation in J774 cell cultures. Her research contributes to the potential use of nanocarriers in immune cells, highlighting her expertise in molecular biology, polymers, and microfluidic techniques.

🔬 Research Interests

Dr. Brenda’s research interests include nanomaterials, molecular biology, polymers, and microfluidics, with a focus on innovative applications of nanoparticles in biomedical contexts.

Publications

Lysosomal Activation Mediated by Endocytosis in J774 Cell Culture Treated with N-Trimethyl Chitosan Nanoparticles

  • Authors: Brenda I. Magaña-Trejo, Aldo Y. Tenorio-Barajas, Bulmaro Cisneros, Victor Altuzar, Sergio Tomas-Velázquez, Claudia Mendoza-Barrera, Efrain Garrido
  • Journal: Molecules
  • Year: 2024